ADMA

ADMA Biologics, Inc.

HealthcareBiotechnologyUSUSDPeers →

$8.69

LiveJun 23, 2026

Market cap

$2.01B

52w range

7.21 – 20.46

P / E

—

EPS · FY 2025

$0.60

Volume

2.89M

Revenue · FY 2025

$510.17M

+19.63% YoY

Explain this page

Arphra AIPlain-English read on ADMA Biologics, Inc.’s valuation

Revenue · 5Y

$510.2M+19.6%

FY21FY22FY23FY24FY25

Net income · 5Y

$146.9M-25.7%

FY21FY22FY23FY24FY25

Margins · FY2025

Gross margin57.4%

Operating margin37.5%

Net margin28.8%

FCF margin5.5%

income_statement_annual

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	YoY
Revenue	510.2M	426.5M	258.2M	154.1M	80.9M	+19.6%
Gross profit	292.8M	219.6M	88.9M	35.3M	1.2M	+33.3%
R&D	4.8M	1.8M	3.3M	3.6M	3.6M	+162.7%
Operating income	191.4M	139.0M	21.6M	−39.4M	−58.4M	+37.7%
Net income	146.9M	197.7M	−28.2M	−65.9M	−71.6M	-25.7%
Diluted EPS	0.60	0.81	-0.13	-0.43	-0.61	-25.9%
Net margin	28.8%	46.4%	-10.9%	-42.8%	-88.5%	—

Pro

Full income statement, balance sheet, and cash-flow history is included with Pro.